HealthRSS

  • January 8, 2007

    New Bill Clears Path For $4 Generics

    A Minnesota state representative is seeking to revamp a decades-old pricing law that retail pharmaceutical giants Wal-Mart Stores Inc. and Target Corp. claim prevents them from offering certain generics drugs at $4 in the state.

  • January 8, 2007

    Bid To Disqualify Hunton & Williams Fails

    A judge ruled Friday that a patent dispute between Enzo Biochem Inc. and Applera Corp. will continue with Hunton & Williams LLP representing Enzo, despite General Electric Co.’s attempt to disqualify the firm that is representing its subsidiary in similar litigation against Enzo.

  • January 8, 2007

    Settlement Reached Over Cancer Test Patents

    Medical testing company PreMD Inc. has entered into a licensing agreement with an inventor, thus resolving a long-running dispute over patents related to tests for detecting breast, lung and colorectal cancer.

  • January 8, 2007

    OCA Chucks Equity Deal To Win Judge’s Favor

    After a bankruptcy judge struck down the orthodontics services company’s Chapter 11 plan Thursday, OCA Inc. has put forth a new plan without the contentious equity deal between a senior lender and some of its shareholders.

  • January 9, 2007

    Sanofi-Aventis Sued By Reps For Overtime Pay

    The U.S. unit of French drug firm Sanofi-Aventis has become the latest target in a series of lawsuits brought by employees accusing pharmaceutical giants of violating state and federal overtime laws.

  • January 8, 2007

    Supreme Court To Hear Home Health Worker's Case

    A home health care worker will get a second chance to plead her case over minimum wage and overtime pay before the U.S. Supreme Court, the court said on Friday.

  • January 9, 2007

    Caltech Launches Suit Over Microsurgical Tools

    The California Institute of Technology has slapped Intuitive Surgical Inc. with a lawsuit, accusing the medical equipment manufacturer of infringing a slew of patents related to a robot-assisted microsurgery system.

  • January 5, 2007

    Federal Circuit Denies Ariad's Request

    In yet another setback for Ariad Pharmaceuticals Inc., a federal appeals court has rejected the drug maker’s request to hear an early appeal of a pretrial ruling in the patent infringement suit filed by rival Amgen Inc.

  • January 5, 2007

    Abbott Facing Stent Injunction After French Ruling

    Drug maker Abbott Laboratories Inc. has been dealt a blow in a patent dispute after a French court ruled a Canadian rival could stop the company from selling a medical device it recently bought from Guidant Corp.

  • January 5, 2007

    Appeals Court Affirms Abbott's Biaxin Injunction

    An appeals court has upheld a lower court’s decision to grant a preliminary injunction barring Andrx Corp. from bringing to market a generic version of Abbott Laboratories’ antibiotic Biaxin XL.

  • January 5, 2007

    Assaulted Women Sue Rite Aid For Negligence

    Six women who were drugged and sexually assaulted by a former Rite Aid Corp. manager have sued the pharmacy chain for $18 million, accusing it of negligence and inadequate supervision of its employees and prescription drugs.

  • January 4, 2007

    Abbott Defeated In HCV Patent Spat

    In a blow to Abbott Laboratories, a federal judge has upheld a jury’s decision to award Belgian biotechnology company Innogenetics NV $7 million in damages in the duo’s long-standing battle over a hepatitis C virus genotyping patent.

  • January 4, 2007

    Eli Lilly Settles Zyprexa Claims

    Eli Lilly & Co. has reached settlements in about 18,000 claims that the company didn’t properly disclose that patients taking Zyprexa, the company’s schizophrenia drug, were at risk to develop diabetes and other disorders, the company said Thursday.

  • January 4, 2007

    Novartis Hits Par With Second Lotrel Suit

    Swiss pharmaceutical giant Novartis International AG has filed another patent suit against Par Pharmaceuticals, seeking to protect the market for billion-dollar hypertension treatment Lotrel.

  • January 4, 2007

    Drug Innovation Stalls Despite R&D Spending: Report

    The number of new medicines to receive a green light from U.S. regulators reached nearly an eight-year low in 2006, while the number of medicines recommended for sale in 2006 and 2005 fell from the annual average of 26 drugs recorded in the previous six years.

  • January 4, 2007

    Duane Morris Wants Another Trial Against McKesson

    Duane Morris LLP wants a new trial against healthcare bigwig McKesson Corp., because, it claims, there is no longer a conflict between its representation of McKesson subsidiaries in a bankruptcy case and its role in a competition suit against the company.

  • January 4, 2007

    Bayer, TrimSpa Settle With FTC Over Ads

    The Federal Trade Commission reached settlements Thursday with a slew of companies, including Bayer AG and TrimSpa maker Goen Technologies Inc., accused of making false claims about their popular weight-loss products.

  • January 5, 2007

    Mintz Levin Snares Health Care Partners For New York

    Mintz Levin has snared two new partners from a Chicago-based rival in an expansion of its New York health law office.

  • January 3, 2007

    Fulwider Pays $8M To Settle Misconduct Claims

    Patent law firm Fulwider Patton Lee & Utecht LLP has settled with ICU Medical Inc. three years after the health care company sued the firm for allegedly breaching its attorney-client obligations.

  • January 3, 2007

    RICO, Antitrust Charges Added To Healthcare Suit

    United Healthcare Corp. will have to add federal racketeering and antitrust charges to its list of legal woes now that a judge has allowed class action plaintiffs to tack the additional charges onto an ongoing suit.